Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 249

1.

Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group.

Anzueto A, Baughman RP, Guntupalli KK, Weg JG, Wiedemann HP, Raventós AA, Lemaire F, Long W, Zaccardelli DS, Pattishall EN.

N Engl J Med. 1996 May 30;334(22):1417-21.

2.

Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome.

Weg JG, Balk RA, Tharratt RS, Jenkinson SG, Shah JB, Zaccardelli D, Horton J, Pattishall EN.

JAMA. 1994 Nov 9;272(18):1433-8.

PMID:
7933425
4.

A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.

Long W, Corbet A, Cotton R, Courtney S, McGuiness G, Walter D, Watts J, Smyth J, Bard H, Chernick V.

N Engl J Med. 1991 Dec 12;325(24):1696-703.

5.

A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.

Hudak ML, Farrell EE, Rosenberg AA, Jung AL, Auten RL, Durand DJ, Horgan MJ, Buckwald S, Belcastro MR, Donohue PK, Carrion V, Maniscalco WW, Balsan MJ, Torres BA, Miller RR, Jansen RD, Graeber JE, Laskay KM, Matteson EJ, Egan EA, Brody AS, Martin DJ, Riddlesberger MM, Montgomery P.

J Pediatr. 1996 Mar;128(3):396-406.

PMID:
8774514
6.

Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group.

Dellinger RP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL, Criner GJ, Davis K Jr, Hyers TM, Papadakos P.

Crit Care Med. 1998 Jan;26(1):15-23.

PMID:
9428538
7.

A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.

Hudak ML, Martin DJ, Egan EA, Matteson EJ, Cummings NJ, Jung AL, Kimberlin LV, Auten RL, Rosenberg AA, Asselin JM, Belcastro MR, Donohue PK, Hamm CR Jr, Jansen RD, Brody AS, Riddlesberger MM, Montgomery P.

Pediatrics. 1997 Jul;100(1):39-50.

PMID:
9200358
8.

Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome.

Spragg RG, Lewis JF, Walmrath HD, Johannigman J, Bellingan G, Laterre PF, Witte MC, Richards GA, Rippin G, Rathgeb F, Häfner D, Taut FJ, Seeger W.

N Engl J Med. 2004 Aug 26;351(9):884-92.

10.

Adult respiratory distress syndrome and artificial surfactant replacement in the pediatric patient.

Perez-Benavides F, Riff E, Franks C.

Pediatr Emerg Care. 1995 Jun;11(3):153-5.

PMID:
7651868
12.

Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant.

Bose C, Corbet A, Bose G, Garcia-Prats J, Lombardy L, Wold D, Donlon D, Long W.

J Pediatr. 1990 Dec;117(6):947-53.

PMID:
2246698
13.

Successful treatment of ARDS with two doses of synthetic surfactant.

Heikinheimo M, Hynynen M, Rautiainen P, Andersson S, Hallman M, Kukkonen S.

Chest. 1994 Apr;105(4):1263-4.

PMID:
8162762
18.

Surfactant therapy in respiratory distress syndrome--the first local experience.

Lim NL, Nordin MM, Cheah IG.

Med J Malaysia. 1994 Mar;49(1):4-11.

19.

Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study.

Domenighetti G, Suter PM, Schaller MD, Ritz R, Perret C.

J Crit Care. 1997 Dec;12(4):177-82.

PMID:
9459113
20.

Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I.

Stevenson D, Walther F, Long W, Sell M, Pauly T, Gong A, Easa D, Pramanik A, LeBlanc M, Anday E, et al.

J Pediatr. 1992 Feb;120(2 Pt 2):S3-12. Erratum in: J Pediatr 1992 May;120(5):762.

PMID:
1735849

Supplemental Content

Support Center